Hedge Funds Say These 5 Penny Stocks are Poised to Explode

Page 5 of 5

1. Taysha Gene Therapies, Inc. (NASDAQ:TSHA)

Share Price as of December 15: $1.64
Stock Price Upside Potential: 291%
Number of Hedge Fund Holders: 16

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is a penny-stock healthcare company that develops and commercializes adeno-associated virus-based gene therapies for treating central nervous system monogenic diseases. Taysha Gene Therapies, Inc. (NASDAQ:TSHA)’s lead product is TSHA-120, used for treating giant axonal neuropathy, and TSHA-102, used for treating Rett syndrome.

Despite going down 1% for the year, Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the penny stocks hedge funds expect to explode. The consensus estimate on Wall Street is a Strong Buy with a $6.07 price target, implying 291% upside potential.

At the end of Q3 2023, 16 hedge funds held stakes in Taysha Gene Therapies, Inc. (NASDAQ:TSHA). The total value of these stakes amounted to $145.38 million. This is compared to 8 positions in the previous quarter with stakes worth $3.34 million. 

Follow Taysha Gene Therapies Inc. (NASDAQ:TSHA)

[/company-follow-email]

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get  the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on 10 Best Stan Druckenmiller Stocks Other Billionaires Are Also Piling Into and 12 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates.

Page 5 of 5